Astria Therapeutics Inc. buy BiotechBee
Start price
20.07.23
/
60%
€8.86
Target price
30.04.26
€10.00
Performance (%)
3.84%
End price
14.12.24
€9.20
Summary
This prediction ended on 14.12.24 with a price of €9.20. The BUY prediction by BiotechBee finished with a performance of 3.84%. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Astria Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0,20 % | 5,47 % | 9,19 % |
| iShares Nasdaq 100 | 2,57 % | 10,09 % | 39,29 % |
| iShares Nikkei 225® | 0,60 % | 9,87 % | 46,20 % |
| iShares S&P 500 | 1,80 % | 7,40 % | 29,62 % |
According to BiotechBee what are the pros and cons of Astria Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Astria Therapeutics Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Astria Therapeutics Inc.
Buy beendet

